Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Banner image

IP LitigationLife Sciences

Law 360: A Dive Into BPCIA Confidential Info Disclosure Requirements

March 15, 2017

IP LitigationLife Sciences

Law 360: A Dive Into BPCIA Confidential Info Disclosure Requirements

March 15, 2017

Back to Fish's Litigation Blog

 

In a recent Law 360 article, Fish attorneys Tasha Francis and Will Orlady discuss the BPCIA Confidential Info Disclosure Requirements. They explore the riddle contained in the first step of the patent dance by looking at three elements:

  1. the statutory language governing the exchange of confidential information.
  2. what parties have done in litigation so far to satisfy this requirement.
  3. what issues remain for future litigants to navigate.

To read the full article, visit Law 360.

Authors: Tasha Francis, Ph.D., Will Orlady

The opinions expressed are those of the authors on the date noted above and do not necessarily reflect the views of Fish & Richardson P.C., any other of its lawyers, its clients, or any of its or their respective affiliates. This post is for general information purposes only and is not intended to be and should not be taken as legal advice. No attorney-client relationship is formed.

Related Tags

BPCIA
Amgen
patent dance
biologics

Blog Authors

Headshot
Tasha M. Francis, Ph.D. | Associate

Tasha Francis, Ph.D., practices intellectual property litigation with an emphasis on patent litigation. Her clients range from solo inventors and emerging companies in the biotechnology and biopharma industries to established international pharmaceutical companies. She has extensive...

Leave a Reply

Your email address will not be published. Required fields are marked *